Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sandy Eldridge

Years Active: 2019-2021
Publications (10 Years): 4

National Cancer Institute

University of Wisconsin–Madison (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute Mar 27o 2011

United States

Senior Scientist/Toxicologist :: Division of Cancer Treatment and Diagnosis

Education History

University of Wisconsin–Madison

United States

PHD :: Toxicology

Publications

Sandy Eldridge, Arianna Scuteri, Eugenia M C Jones, Guido Cavaletti, Liang Guo, Elizabeth Glaze
Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy. Toxics 9 (11) (2021)
Eugene Herman, Sandy Eldridge
Spontaneously occurring cardiovascular lesions in commonly used laboratory animals. Cardio-oncology (London, England) 5 (2019)
Sandy Eldridge, Liang Guo, John Hamre
A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models. Toxicologic pathology 48 (1) (2019)
Choh Yeung, Anna E Gibson, Sameer H Issaq, Nobu Oshima, Joshua T Baumgart, Leah D Edessa, Ganesha Rai, Daniel J Urban, Michelle S Johnson, Gloria A Benavides, Giuseppe L Squadrito, Marielle E Yohe, Haiyan Lei, Sandy Eldridge, John Hamre, Tyrone Dowdy, Victor Ruiz-Rodado, Adrian Lita, Arnulfo Mendoza, Jack F Shern, Mioara Larion, Lee J Helman, Gordon M Stott, Murali C Krishna, Matthew D Hall, Victor Darley-Usmar, Leonard M Neckers, Christine M Heske
Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma. Cancer research 79 (19) (2019)

Sandy Eldridge.css-eqlu8i{font-size:small;padding-left:4px;}